Ubs Group Ag Midatech Pharma PLC Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.46 - $1.0 $807 - $1,755	-1,755 Reduced 35.74%	3,155 $2,000
Q1 2022 May 16, 2022	BUY	$0.83 - $1.26 $4,075 - $6,186	4,910 New	4,910 $4,000
Q3 2021 Nov 15, 2021	SELL	$1.68 - $2.19 $12,947 - $16,878	-7,707 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$1.78 - $2.95 $29,663 - $49,161	-16,665 Reduced 68.38%	7,707 $16,000
Q1 2021 May 12, 2021	BUY	$1.92 - $3.8 $44,901 - $88,866	23,386 Added 2371.81%	24,372 $52,000
Q4 2020 Feb 11, 2021	BUY	$1.77 - $2.36 $1,745 - $2,326	986 New	986 $2,000
Q3 2020 Nov 12, 2020	SELL	$1.29 - $4.3 $39,814 - $132,715	-30,864 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$1.25 - $3.98 $34,868 - $111,022	27,895 Added 939.54%	30,864 $42,000
Q1 2020 May 01, 2020	BUY	$1.22 - $5.2 $3,622 - $15,438	2,969 New	2,969 $5,000

Ticker MTP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,939,740
Market Cap $512K
Description
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.